MYC and breast carcinoma: Consistent with its negative regulatory role on cell growth, the endogenous level of MBP-1 in tumor cells is low; in MCF-7 breast cancer cells, glucose concentration and hypoxia have been reported to modulate MBP-1 expression and its binding to the c-MYC promoter, consequently affecting cell proliferation [21,22].